264 related articles for article (PubMed ID: 30051264)
1. Quality of life outcomes in patients with localised renal cancer: a literature review.
Rossi SH; Klatte T; Stewart GD
World J Urol; 2018 Dec; 36(12):1961-1972. PubMed ID: 30051264
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients.
Beisland E; Beisland C; Hjelle KM; Bakke A; Aarstad AK; Aarstad HJ
Scand J Urol; 2015; 49(4):282-9. PubMed ID: 25515950
[TBL] [Abstract][Full Text] [Related]
3. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
[TBL] [Abstract][Full Text] [Related]
4. Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research.
Lebentrau S; Rauter S; Baumunk D; Christoph F; König F; May M; Schostak M
World J Urol; 2017 May; 35(5):753-759. PubMed ID: 27520385
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer.
MacLennan S; Imamura M; Lapitan MC; Omar MI; Lam TB; Hilvano-Cabungcal AM; Royle P; Stewart F; MacLennan G; MacLennan SJ; Dahm P; Canfield SE; McClinton S; Griffiths TR; Ljungberg B; N'Dow J; ;
Eur Urol; 2012 Dec; 62(6):1097-117. PubMed ID: 22841673
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting health-related quality of life recovery in patients undergoing surgical treatment for renal tumors: prospective evaluation using the RAND SF-36 Health Survey.
Novara G; Secco S; Botteri M; De Marco V; Artibani W; Ficarra V
Eur Urol; 2010 Jan; 57(1):112-20. PubMed ID: 19406562
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma.
Gratzke C; Seitz M; Bayrle F; Schlenker B; Bastian PJ; Haseke N; Bader M; Tilki D; Roosen A; Karl A; Reich O; Khoder WY; Wyler S; Stief CG; Staehler M; Bachmann A
BJU Int; 2009 Aug; 104(4):470-5. PubMed ID: 19239445
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term results after nephron-sparing surgery and radical nephrectomy in treating 4- to 7-cm renal cell carcinoma.
Milonas D; Skulčius G; Baltrimavičius R; Auškalnis S; Kinčius M; Matjošaitis A; Gudinavičienė I; Smailytė G; Jievaltas M
Medicina (Kaunas); 2013; 49(5):223-8. PubMed ID: 24247918
[TBL] [Abstract][Full Text] [Related]
9. Nephron sparing surgery in tumours greater than 7cm.
de Saint Aubert N; Audenet F; Mccaig F; Delavaud C; Verkarre V; Le Guilchet T; Dariane C; Pettenati C; Slaoui H; Mejean A; Timsit MO
Prog Urol; 2018 May; 28(6):336-343. PubMed ID: 29699856
[TBL] [Abstract][Full Text] [Related]
10. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
[TBL] [Abstract][Full Text] [Related]
12. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
[TBL] [Abstract][Full Text] [Related]
13. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients.
Beisland E; Aarstad HJ; Aarstad AK; Bakke A; Bostad L; Beisland C
Acta Oncol; 2016; 55(3):349-56. PubMed ID: 26251300
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
15. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
[TBL] [Abstract][Full Text] [Related]
16. Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.
Ficarra V; Novella G; Sarti A; Novara G; Galfano A; Cavalleri S; Artibani W
Int Urol Nephrol; 2002; 34(4):441-6. PubMed ID: 14577481
[TBL] [Abstract][Full Text] [Related]
17. Perioperative and renal functional outcomes of laparoscopic partial nephrectomy (LPN) for renal tumours of high surgical complexity: a single-institute comparison between clampless and clamped procedures.
Verze P; Fedelini P; Chiancone F; Cucchiara V; La Rocca R; Fedelini M; Meccariello C; Palmieri A; Mirone V
World J Urol; 2017 Mar; 35(3):403-409. PubMed ID: 27324881
[TBL] [Abstract][Full Text] [Related]
18. Treatment of localised renal cell carcinoma.
Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: risks and benefits of nephron-sparing surgery for T1 tumors.
Ghandour RA; Danzig MR; McKiernan JM
Adv Chronic Kidney Dis; 2015 Jul; 22(4):258-65. PubMed ID: 26088069
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.
Shvero A; Nativ O; Abu-Ghanem Y; Zilberman D; Zaher B; Levitt M; Fridman E; Portnoy O; Ramon J; Dotan ZA
Clin Genitourin Cancer; 2018 Jun; 16(3):e613-e617. PubMed ID: 29174471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
